{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:29:37Z","timestamp":1789662577026,"version":"4.0.1"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12035-023-03798-7","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:02:23Z","timestamp":1700733743000},"page":"3503-3527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders"],"prefix":"10.1007","volume":"61","author":[{"given":"Saman","family":"Yasamineh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Jabbari","family":"Mehrabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Derafsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renizo","family":"Danihiel Cosimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad Karimi","family":"Forood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meead","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-6437","authenticated-orcid":false,"given":"Omid","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"issue":"4","key":"3798_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ceb.2010.05.004","volume":"22","author":"FR Maxfield","year":"2010","unstructured":"Maxfield FR, van Meer G (2010) Cholesterol, the central lipid of mammalian cells. Curr Opin Cell Biol 22(4):422\u2013429","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"3798_CR2","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.7150\/jca.63609","volume":"13","author":"X Guo","year":"2022","unstructured":"Guo X et al (2022) Cholesterol metabolism and its implication in glioblastoma therapy. J Cancer 13(6):1745","journal-title":"J Cancer"},{"issue":"2","key":"3798_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/1673-5374.317956","volume":"17","author":"BL Tang","year":"2022","unstructured":"Tang BL (2022) Cholesterol synthesis inhibition or depletion in axon regeneration. Neural Regen Res 17(2):271","journal-title":"Neural Regen Res"},{"issue":"665","key":"3798_CR4","doi-asserted-by":"publisher","first-page":"eadc9967","DOI":"10.1126\/scitranslmed.adc9967","volume":"14","author":"A Haider","year":"2022","unstructured":"Haider A et al (2022) Assessment of cholesterol homeostasis in the living human brain. Sci Transl Med 14(665):eadc9967","journal-title":"Sci Transl Med"},{"issue":"1","key":"3798_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-0965-z","volume":"18","author":"G Hussain","year":"2019","unstructured":"Hussain G et al (2019) Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis 18(1):1\u201312","journal-title":"Lipids Health Dis"},{"issue":"11","key":"3798_CR6","doi-asserted-by":"publisher","first-page":"e50262","DOI":"10.1371\/journal.pone.0050262","volume":"7","author":"H Appelqvist","year":"2012","unstructured":"Appelqvist H et al (2012) Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content. PLoS one 7(11):e50262","journal-title":"PLoS one"},{"issue":"4","key":"3798_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s11011-017-0021-5","volume":"32","author":"SS Saeedi Saravi","year":"2017","unstructured":"Saeedi Saravi SS et al (2017) The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Metab Brain Dis 32(4):949\u2013965","journal-title":"Metab Brain Dis"},{"issue":"4","key":"3798_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1021\/acschemneuro.2c00645","volume":"14","author":"D Sarmah","year":"2023","unstructured":"Sarmah D et al (2023) Cardiolipin-mediated alleviation of mitochondrial dysfunction is a neuroprotective effect of statin in animal model of ischemic stroke. ACS Chem Neurosci 14(4):709\u2013724","journal-title":"ACS Chem Neurosci"},{"key":"3798_CR9","doi-asserted-by":"crossref","unstructured":"Susanto M et al (2023) The neuroprotective effect of statin in traumatic brain injury: a systematic review. World Neurosurg: X 100211.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/37251243\/","DOI":"10.1016\/j.wnsx.2023.100211"},{"key":"3798_CR10","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.crphar.2020.100012","volume":"2","author":"A Bhat","year":"2021","unstructured":"Bhat A et al (2021) Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: an expository appraisal. Curr Res Pharmacol Drug Discov 2:100012","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"6","key":"3798_CR11","first-page":"746","volume":"5","author":"JE Vance","year":"2012","unstructured":"Vance JE (2012) Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech 5(6):746\u2013755","journal-title":"Dis Model Mech"},{"issue":"5","key":"3798_CR12","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1074\/jbc.TM118.004165","volume":"294","author":"SR Pfeffer","year":"2019","unstructured":"Pfeffer SR (2019) NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes. J Biol Chem 294(5):1706\u20131709","journal-title":"J Biol Chem"},{"issue":"4","key":"3798_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mds.26152","volume":"30","author":"X Huang","year":"2015","unstructured":"Huang X et al (2015) Statins, plasma cholesterol, and risk of Parkinson\u2019s disease: a prospective study. Mov Disord 30(4):552\u2013559","journal-title":"Mov Disord"},{"issue":"13","key":"3798_CR14","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.3390\/ijerph20136217","volume":"20","author":"M Passero","year":"2023","unstructured":"Passero M, Zhai T, Huang Z (2023) Investigation of potential drug targets for cholesterol regulation to treat Alzheimer\u2019s disease. Int J Environ Res Public Health 20(13):6217","journal-title":"Int J Environ Res Public Health"},{"key":"3798_CR15","doi-asserted-by":"crossref","unstructured":"Luo Y et al (2022) Measurement of 7-dehydrocholesterol and cholesterol in hair can be used in the diagnosis of Smith-Lemli-Opitz syndrome. J Lipid Res 63(6).\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/35577137\/","DOI":"10.1016\/j.jlr.2022.100228"},{"issue":"5","key":"3798_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","volume":"15","author":"C Salata","year":"2017","unstructured":"Salata C et al (2017) Antiviral activity of cationic amphiphilic drugs. Expert Rev Anti Infect Ther 15(5):483\u2013492","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"3798_CR17","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1099\/vir.0.18883-0","volume":"84","author":"M Nawa","year":"2003","unstructured":"Nawa M et al (2003) Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J Gen Virol 84(7):1737\u20131741","journal-title":"J Gen Virol"},{"issue":"9","key":"3798_CR18","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1021\/acs.jcim.1c00903","volume":"61","author":"TR Lane","year":"2021","unstructured":"Lane TR, Ekins S (2021) Defending antiviral cationic amphiphilic drugs that may cause drug-induced phospholipidosis. J Chem Inf Model 61(9):4125\u20134130","journal-title":"J Chem Inf Model"},{"issue":"1","key":"3798_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-25399-5","volume":"12","author":"M Morin-Dewaele","year":"2022","unstructured":"Morin-Dewaele M et al (2022) Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry. Sci Rep 12(1):1\u201312","journal-title":"Sci Rep"},{"key":"3798_CR20","doi-asserted-by":"crossref","unstructured":"Lu F et al (2015) Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. Elife 4.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/26646182\/","DOI":"10.7554\/eLife.12177"},{"issue":"20","key":"3798_CR21","doi-asserted-by":"publisher","first-page":"11796","DOI":"10.1016\/S0021-9258(18)80136-3","volume":"264","author":"L Liscum","year":"1989","unstructured":"Liscum L, Faust JR (1989) The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-\u03b2-[2-(diethylamino) ethoxy] androst-5-en-17-one. J Biol Chem 264(20):11796\u201311806","journal-title":"J Biol Chem"},{"key":"3798_CR22","doi-asserted-by":"crossref","unstructured":"Assefi M et al (2023) Potential use of the cholesterol transfer inhibitor U18666A as an antiviral drug for research on various viral infections. Microb Pathog 106096.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/37011734\/","DOI":"10.1016\/j.micpath.2023.106096"},{"issue":"17","key":"3798_CR23","doi-asserted-by":"publisher","first-page":"14850","DOI":"10.1074\/jbc.M300488200","volume":"278","author":"KM Wojtanik","year":"2003","unstructured":"Wojtanik KM, Liscum L (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278(17):14850\u201314856","journal-title":"J Biol Chem"},{"issue":"3733","key":"3798_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1126\/science.153.3733.312","volume":"153","author":"N Winer","year":"1966","unstructured":"Winer N et al (1966) Myotonic response induced by inhibitors of cholesterol biosynthesis. Science 153(3733):312\u2013313","journal-title":"Science"},{"issue":"11","key":"3798_CR25","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.cellsig.2006.04.006","volume":"18","author":"CHV Koh","year":"2006","unstructured":"Koh CHV, Cheung NS (2006) Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer\u2019s disease. Cell Signal 18(11):1844\u20131853","journal-title":"Cell Signal"},{"key":"3798_CR26","doi-asserted-by":"crossref","unstructured":"Croce C et al (2022) Efficient cholesterol transport in dendritic cells defines optimal exogenous antigen presentation and toxoplasma gondii proliferation. Front Cell Dev Biol 10.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/35309938\/","DOI":"10.3389\/fcell.2022.837574"},{"issue":"4","key":"3798_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1471-4159.1982.tb05332.x","volume":"38","author":"JJ Volpe","year":"1982","unstructured":"Volpe JJ, Obert KA (1982) Interrelationships of ubiquinone and sterol syntheses in cultured cells of neural origin. J Neurochem 38(4):931\u2013938","journal-title":"J Neurochem"},{"issue":"6","key":"3798_CR28","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/ijms24065525","volume":"24","author":"TC Harned","year":"2023","unstructured":"Harned TC et al (2023) Acute ACAT1\/SOAT1 blockade increases MAM Cholesterol and strengthens ER-mitochondria connectivity. Int J Mol Sci 24(6):5525","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3798_CR29","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","volume":"165","author":"X Gong","year":"2016","unstructured":"Gong X et al (2016) Structural insights into the Niemann-Pick C1 (NPC1)-mediated cholesterol transfer and Ebola infection. Cell 165(6):1467\u20131478","journal-title":"Cell"},{"issue":"9","key":"3798_CR30","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1242\/jcs.02324","volume":"118","author":"P Lajoie","year":"2005","unstructured":"Lajoie P et al (2005) The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. J Cell Sci 118(9):1991\u20132003","journal-title":"J Cell Sci"},{"issue":"24","key":"3798_CR31","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1128\/JVI.01053-16","volume":"90","author":"F Elgner","year":"2016","unstructured":"Elgner F et al (2016) The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus. J Virol 90(24):11181\u201311196","journal-title":"J Virol"},{"issue":"6","key":"3798_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11745-009-3305-7","volume":"44","author":"RJ Cenedella","year":"2009","unstructured":"Cenedella RJ (2009) Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44(6):477\u2013487","journal-title":"Lipids"},{"issue":"12","key":"3798_CR33","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1016\/S0021-9258(17)42859-6","volume":"259","author":"SR Panini","year":"1984","unstructured":"Panini SR, Sexton R, Rudney H (1984) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by oxysterol by-products of cholesterol biosynthesis. Possible mediators of low density lipoprotein action. J Biol Chem 259(12):7767\u20137771","journal-title":"J Biol Chem"},{"issue":"5","key":"3798_CR34","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1083\/jcb.108.5.1625","volume":"108","author":"L Liscum","year":"1989","unstructured":"Liscum L, Ruggiero RM, Faust JR (1989) The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J Cell Biol 108(5):1625\u20131636","journal-title":"J Cell Biol"},{"key":"3798_CR35","doi-asserted-by":"crossref","unstructured":"Peake KB et al (2007) Inflammation in the Niemann\u2010Pick type\u2010C brain. Wiley Online Library.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2902432\/","DOI":"10.1096\/fasebj.21.5.A234-d"},{"key":"3798_CR36","doi-asserted-by":"crossref","unstructured":"Peruzzu D et al (2022) Inhibition of cholesterol transport impairs Cav\u20101 trafficking and small extracellular vesicles secretion, promoting amphisome formation in melanoma cells. Traffic.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/36519961\/","DOI":"10.1111\/tra.12878"},{"issue":"9","key":"3798_CR37","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1210\/en.2009-0410","volume":"150","author":"M-C Battista","year":"2009","unstructured":"Battista M-C et al (2009) 24-dehydrocholesterol reductase\/seladin-1: a key protein differentially involved in adrenocorticotropin effects observed in human and rat adrenal cortex. Endocrinology 150(9):4180\u20134190","journal-title":"Endocrinology"},{"issue":"5","key":"3798_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10571-015-0263-x","volume":"36","author":"K Yao","year":"2016","unstructured":"Yao K et al (2016) Protective effect of DHT on apoptosis induced by U18666A via PI3K\/Akt signaling pathway in C6 glial cell lines. Cell Mol Neurobiol 36(5):801\u2013809","journal-title":"Cell Mol Neurobiol"},{"key":"3798_CR39","doi-asserted-by":"publisher","first-page":"e12177","DOI":"10.7554\/eLife.12177","volume":"4","author":"F Lu","year":"2015","unstructured":"Lu F et al (2015) Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. Elife 4:e12177","journal-title":"Elife"},{"issue":"1","key":"3798_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1021\/acschembio.6b00849","volume":"12","author":"SA Head","year":"2017","unstructured":"Head SA et al (2017) Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of mTOR signaling and angiogenesis. ACS Chem Biol 12(1):174\u2013182","journal-title":"ACS Chem Biol"},{"issue":"30","key":"3798_CR41","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1073\/pnas.1705304114","volume":"114","author":"W Eid","year":"2017","unstructured":"Eid W et al (2017) mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proc Natl Acad Sci 114(30):7999\u20138004","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3798_CR42","doi-asserted-by":"publisher","first-page":"e2024149118","DOI":"10.1073\/pnas.2024149118","volume":"118","author":"X Xiao","year":"2021","unstructured":"Xiao X et al (2021) Selective Aster inhibitors distinguish vesicular and nonvesicular sterol transport mechanisms. Proc Natl Acad Sci 118(2):e2024149118","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"3798_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/mol.54.3.591","volume":"54","author":"FF Moebius","year":"1998","unstructured":"Moebius FF et al (1998) Pharmacological analysis of sterol \u03948-\u03947 isomerase proteins with [3H] ifenprodil. Mol Pharmacol 54(3):591\u2013598","journal-title":"Mol Pharmacol"},{"issue":"2","key":"3798_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/bj3260609","volume":"326","author":"S-H Bae","year":"1997","unstructured":"Bae S-H, Paik Y-K (1997) Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol \u039424-reductase. Biochem J 326(2):609\u2013616","journal-title":"Biochem J"},{"issue":"6","key":"3798_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/diagnostics10060409","volume":"10","author":"M Allam","year":"2020","unstructured":"Allam M et al (2020) COVID-19 diagnostics, tools, and prevention. Diagnostics 10(6):409","journal-title":"Diagnostics"},{"key":"3798_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cca.2016.02.024","volume":"456","author":"Z Xue-Shan","year":"2016","unstructured":"Xue-Shan Z et al (2016) Imbalanced cholesterol metabolism in Alzheimer\u2019s disease. Clin Chim Acta 456:107\u2013114","journal-title":"Clin Chim Acta"},{"issue":"2","key":"3798_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-021-00582-x","volume":"32","author":"K Pang","year":"2022","unstructured":"Pang K et al (2022) An App knock-in rat model for Alzheimer\u2019s disease exhibiting A\u03b2 and tau pathologies, neuronal death and cognitive impairments. Cell Res 32(2):157\u2013175","journal-title":"Cell Res"},{"issue":"11","key":"3798_CR48","doi-asserted-by":"publisher","first-page":"e00529","DOI":"10.1128\/MCB.00529-17","volume":"38","author":"J Chung","year":"2018","unstructured":"Chung J et al (2018) Endosomal-lysosomal cholesterol sequestration by U18666A differentially regulates amyloid precursor protein (APP) metabolism in normal and APP-overexpressing cells. Mol Cell Biol 38(11):e00529-e617","journal-title":"Mol Cell Biol"},{"key":"3798_CR49","doi-asserted-by":"crossref","unstructured":"Li Y et al (2021) Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. Iscience 24(5).\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34013171\/","DOI":"10.1016\/j.isci.2021.102457"},{"issue":"14","key":"3798_CR50","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.3390\/ijms21145149","volume":"21","author":"C-O Wong","year":"2020","unstructured":"Wong C-O (2020) Endosomal-lysosomal processing of neurodegeneration-associated proteins in astrocytes. Int J Mol Sci 21(14):5149","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3798_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1021\/jasms.2c00342","volume":"34","author":"A Cougnoux","year":"2023","unstructured":"Cougnoux A et al (2023) Investigation of 2-hydroxypropyl-\u03b2-cyclodextrin treatment in a neuronal-like cell model of Niemann-Pick type C using quantitative proteomics. J Am Soc Mass Spectrom 34(4):668\u2013675","journal-title":"J Am Soc Mass Spectrom"},{"issue":"2","key":"3798_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejcb.2017.01.002","volume":"96","author":"I Eriksson","year":"2017","unstructured":"Eriksson I et al (2017) Impact of high cholesterol in a Parkinson\u2019s disease model: prevention of lysosomal leakage versus stimulation of \u03b1-synuclein aggregation. Eur J Cell Biol 96(2):99\u2013109","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"3798_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jcp.20912","volume":"211","author":"CHV Koh","year":"2007","unstructured":"Koh CHV et al (2007) Neuronal apoptosis mediated by inhibition of intracellular cholesterol transport: microarray and proteomics analyses in cultured murine cortical neurons. J Cell Physiol 211(1):63\u201387","journal-title":"J Cell Physiol"},{"issue":"5","key":"3798_CR54","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1523\/JNEUROSCI.22-05-01679.2002","volume":"22","author":"H Runz","year":"2002","unstructured":"Runz H et al (2002) Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22(5):1679\u20131689","journal-title":"J Neurosci"},{"issue":"1","key":"3798_CR55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.antiviral.2011.11.014","volume":"93","author":"MK Poh","year":"2012","unstructured":"Poh MK et al (2012) U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res 93(1):191\u2013198","journal-title":"Antiviral Res"},{"issue":"5","key":"3798_CR56","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1091\/mbc.11.5.1829","volume":"11","author":"T Kobayashi","year":"2000","unstructured":"Kobayashi T et al (2000) The tetraspanin CD63\/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11(5):1829\u20131843","journal-title":"Mol Biol Cell"},{"issue":"2","key":"3798_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/10084","volume":"1","author":"T Kobayashi","year":"1999","unstructured":"Kobayashi T et al (1999) Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1(2):113\u2013118","journal-title":"Nat Cell Biol"},{"issue":"2","key":"3798_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1034\/j.1600-0749.2003.00027.x","volume":"16","author":"AM Hall","year":"2003","unstructured":"Hall AM, Krishnamoorthy L, Orlow SJ (2003) Accumulation of tyrosinase in the endolysosomal compartment is induced by U18666A. Pigment Cell Res 16(2):149\u2013158","journal-title":"Pigment Cell Res"},{"issue":"2","key":"3798_CR59","first-page":"261","volume":"29","author":"J Kuszak","year":"1988","unstructured":"Kuszak J, Khan A, Cenedella R (1988) An ultrastructural analysis of plasma membrane in the U18666A cataract. Invest Ophthalmol Vis Sci 29(2):261\u2013267","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3798_CR60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/bj2410345","volume":"241","author":"A Boogaard","year":"1987","unstructured":"Boogaard A, Griffioen M, Cohen LH (1987) Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity. Biochem J 241(2):345\u2013351","journal-title":"Biochem J"},{"key":"3798_CR61","doi-asserted-by":"crossref","unstructured":"M\u00fcller C et al (2022) Dehydrocholesterol reductase 24 (DHCR24): medicinal chemistry, pharmacology and novel therapeutic options. Curr Med Chem.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34781860\/","DOI":"10.2174\/0929867328666211115121832"},{"issue":"4","key":"3798_CR62","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.7150\/ijbs.68015","volume":"18","author":"H-Y Peng","year":"2022","unstructured":"Peng H-Y et al (2022) PrPC promotes endometriosis progression by reprogramming cholesterol metabolism and estrogen biosynthesis of endometrial stromal cells through PPAR\u03b1 pathway. Int J Biol Sci 18(4):1755","journal-title":"Int J Biol Sci"},{"issue":"3","key":"3798_CR63","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2249.2008.03779.x","volume":"155","author":"EKI Iftakhar","year":"2009","unstructured":"Iftakhar EKI et al (2009) Novel mechanism of U18666A-induced tumour necrosis factor-alpha production in RAW 264.7 macrophage cells. Clin Exp Immunol 155(3):552\u20138","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3798_CR64","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbrc.2004.01.066","volume":"315","author":"NS Cheung","year":"2004","unstructured":"Cheung NS et al (2004) Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons. Biochem Biophys Res Commun 315(2):408\u2013417","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3798_CR65","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1471-4159.2006.03958.x","volume":"98","author":"CHV Koh","year":"2006","unstructured":"Koh CHV et al (2006) Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons. J Neurochem 98(4):1278\u20131289","journal-title":"J Neurochem"},{"issue":"15","key":"3798_CR66","doi-asserted-by":"publisher","first-page":"10j","DOI":"10.1016\/0002-9149(88)90002-1","volume":"62","author":"AW Alberts","year":"1988","unstructured":"Alberts AW (1988) Discovery, biochemistry and biology of lovastatin. Am J Cardiol 62(15):10j\u201315j","journal-title":"Am J Cardiol"},{"issue":"8","key":"3798_CR67","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/cns.12420","volume":"21","author":"A Mendoza-Oliva","year":"2015","unstructured":"Mendoza-Oliva A et al (2015) Lovastatin differentially affects neuronal cholesterol and amyloid-\u03b2 production in vivo and in vitro. CNS Neurosci Ther 21(8):631\u2013641","journal-title":"CNS Neurosci Ther"},{"key":"3798_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jns.2018.01.015","volume":"386","author":"F Yang","year":"2018","unstructured":"Yang F et al (2018) Lovastatin promotes myelin formation in NPC1 mutant oligodendrocytes. J Neurol Sci 386:56\u201363","journal-title":"J Neurol Sci"},{"key":"3798_CR69","doi-asserted-by":"crossref","unstructured":"Carroll CB, Webb D, Stevens KN (2019) Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study. 9(10):e029740.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/31594876\/","DOI":"10.1136\/bmjopen-2019-029740"},{"issue":"3","key":"3798_CR70","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/WAD.0b013e3181d61fea","volume":"24","author":"A Serrano-Pozo","year":"2010","unstructured":"Serrano-Pozo A et al (2010) Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. Alzheimer Dis Assoc Disord 24(3):220\u2013226","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"3798_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1043-6618(02)00288-8","volume":"47","author":"Y-X Sun","year":"2003","unstructured":"Sun Y-X et al (2003) Pravastatin inhibits pro-inflammatory effects of Alzheimer\u2019s peptide A\u03b21\u201342 in glioma cell culture in vitro. Pharmacol Res 47(2):119\u2013126","journal-title":"Pharmacol Res"},{"key":"3798_CR72","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00702-011-0680-z","volume":"118","author":"AC Tramontina","year":"2011","unstructured":"Tramontina AC et al (2011) The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer\u2019s disease in rats. J Neural Transm 118:1641\u20131649","journal-title":"J Neural Transm"},{"issue":"12","key":"3798_CR73","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","volume":"74","author":"H Feldman","year":"2010","unstructured":"Feldman H et al (2010) Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 74(12):956\u2013964","journal-title":"Neurology"},{"key":"3798_CR74","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2165\/00003495-199753050-00011","volume":"53","author":"AP Lea","year":"1997","unstructured":"Lea AP, McTavish D (1997) Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 53:828\u2013847","journal-title":"Drugs"},{"key":"3798_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.enganabound.2022.08.010","volume":"144","author":"Y Peng","year":"2022","unstructured":"Peng Y et al (2022) A molecular dynamic approach to a hypothesis on the dynamical behavior of Rosuvastatin on Alzheimer\u2019s disease amyloid beta-peptide interactions in the atomic structures. Eng Anal Boundary Elem 144:1\u20137","journal-title":"Eng Anal Boundary Elem"},{"key":"3798_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2017.01.063","volume":"642","author":"SY Kang","year":"2017","unstructured":"Kang SY et al (2017) Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson\u2019s disease. Neurosci Lett 642:20\u201326","journal-title":"Neurosci Lett"},{"key":"3798_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.09.003","volume":"143","author":"D Yao","year":"2018","unstructured":"Yao D et al (2018) Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer\u2019s disease and protection effects of zinc and fluvastatin. Brain Res Bull 143:1\u20138","journal-title":"Brain Res Bull"},{"issue":"4","key":"3798_CR78","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q (2015) Cholesterol metabolism and homeostasis in the brain. Protein Cell 6(4):254\u2013264","journal-title":"Protein Cell"},{"key":"3798_CR79","doi-asserted-by":"publisher","first-page":"766587","DOI":"10.3389\/fnagi.2021.766587","volume":"13","author":"FW Pfrieger","year":"2021","unstructured":"Pfrieger FW (2021) Neurodegenerative diseases and cholesterol: seeing the field through the players. Front Aging Neurosci 13:766587","journal-title":"Front Aging Neurosci"},{"key":"3798_CR80","doi-asserted-by":"crossref","unstructured":"Vance JE, Hayashi H, Karten B (2005) Cholesterol homeostasis in neurons and glial cells. In Semin Cell Dev Biol. Elsevier.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/15797830\/","DOI":"10.1016\/j.semcdb.2005.01.005"},{"issue":"5","key":"3798_CR81","doi-asserted-by":"publisher","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","volume":"28","author":"U Jin","year":"2019","unstructured":"Jin U, Park SJ, Park SM (2019) Cholesterol metabolism in the brain and its association with Parkinson\u2019s disease. Exp Neurobiol 28(5):554","journal-title":"Exp Neurobiol"},{"key":"3798_CR82","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","volume":"58","author":"L Dai","year":"2021","unstructured":"Dai L et al (2021) Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Neurobiol 58:2183\u20132201","journal-title":"Mol Neurobiol"},{"issue":"7","key":"3798_CR83","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW (2016) Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arterioscler Thromb Vasc Biol 36(7):1305\u20131315","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3798_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5607\/en23010","volume":"32","author":"SY Cheon","year":"2023","unstructured":"Cheon SY (2023) Impaired cholesterol metabolism, neurons, and neuropsychiatric disorders. Exp Neurobiol 32(2):57","journal-title":"Exp Neurobiol"},{"issue":"1","key":"3798_CR85","doi-asserted-by":"publisher","first-page":"30928","DOI":"10.1038\/srep30928","volume":"6","author":"M Moutinho","year":"2016","unstructured":"Moutinho M et al (2016) Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk. Sci Rep 6(1):30928","journal-title":"Sci Rep"},{"issue":"10","key":"3798_CR86","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","volume":"15","author":"AR Koudinov","year":"2001","unstructured":"Koudinov AR, Koudinova NV (2001) Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 15(10):1858\u20131860","journal-title":"FASEB J"},{"key":"3798_CR87","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","volume":"229","author":"AR Koudinov","year":"2005","unstructured":"Koudinov AR, Koudinova NV (2005) Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci 229:233\u2013240","journal-title":"J Neurol Sci"},{"issue":"S 2","key":"3798_CR88","first-page":"107","volume":"36","author":"AR Koudinov","year":"2003","unstructured":"Koudinov AR, Koudinova NV (2003) Cholesterol, synaptic function and Alzheimer\u2019s disease. Pharmacopsychiatry 36(S 2):107\u2013112","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"3798_CR89","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/antibiotics12010122","volume":"12","author":"F Bruno","year":"2023","unstructured":"Bruno F et al (2023) The antifungal antibiotic filipin as a diagnostic tool of cholesterol alterations in lysosomal storage diseases and neurodegenerative disorders. Antibiotics 12(1):122","journal-title":"Antibiotics"},{"key":"3798_CR90","doi-asserted-by":"crossref","unstructured":"Cherry P et al (2023) Loss of small GTPase Rab7 activation in prion infection negatively affects a feedback loop regulating neuronal cholesterol metabolism. J Biol Chem 102883.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/36623732\/","DOI":"10.1016\/j.jbc.2023.102883"},{"issue":"1","key":"3798_CR91","doi-asserted-by":"publisher","first-page":"101976","DOI":"10.1016\/j.xpro.2022.101976","volume":"4","author":"A-C Raulin","year":"2023","unstructured":"Raulin A-C, Liu C-C, Bu G (2023) An assay to evaluate the capacity of cholesterol acceptors using BODIPY-cholesterol in cells. STAR Protoc 4(1):101976","journal-title":"STAR Protoc"},{"issue":"10","key":"3798_CR92","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","volume":"7","author":"JM Karasinska","year":"2011","unstructured":"Karasinska JM, Hayden MR (2011) Cholesterol metabolism in Huntington disease. Nat Rev Neurol 7(10):561\u2013572","journal-title":"Nat Rev Neurol"},{"key":"3798_CR93","doi-asserted-by":"crossref","unstructured":"Dietschy JM (2009) Central nervous system: cholesterol turnover, brain development and neurodegeneration.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/19166320\/","DOI":"10.1515\/BC.2009.035"},{"issue":"8","key":"3798_CR94","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45(8):1375\u20131397","journal-title":"J Lipid Res"},{"issue":"5","key":"3798_CR95","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","volume":"58","author":"L Dai","year":"2021","unstructured":"Dai L et al (2021) Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Neurobiol 58(5):2183\u20132201","journal-title":"Mol Neurobiol"},{"issue":"18","key":"3798_CR96","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.3390\/s21186064","volume":"21","author":"R Martinek","year":"2021","unstructured":"Martinek R et al (2021) Advanced bioelectrical signal processing methods: past, present, and future approach\u2014part III: other biosignals. Sensors 21(18):6064","journal-title":"Sensors"},{"issue":"8","key":"3798_CR97","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/hipo.20548","volume":"19","author":"L Fester","year":"2009","unstructured":"Fester L et al (2009) Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus 19(8):692\u2013705","journal-title":"Hippocampus"},{"issue":"2","key":"3798_CR98","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0005-2736(03)00024-5","volume":"1610","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta (BBA)-Biomembr 1610(2):271\u2013280","journal-title":"Biochim Biophys Acta (BBA)-Biomembr"},{"issue":"1","key":"3798_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00710-4","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan Y et al (2022) Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther 7(1):1\u201329","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3798_CR100","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song B-L (2020) Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol 21(4):225\u2013245","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"3798_CR101","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.3390\/ijms20163858","volume":"20","author":"K Mouzat","year":"2019","unstructured":"Mouzat K et al (2019) Regulation of brain cholesterol: what role do liver X receptors play in neurodegenerative diseases? Int J Mol Sci 20(16):3858","journal-title":"Int J Mol Sci"},{"issue":"14","key":"3798_CR102","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1074\/jbc.M313828200","volume":"279","author":"H Hayashi","year":"2004","unstructured":"Hayashi H et al (2004) Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem 279(14):14009\u201314015","journal-title":"J Biol Chem"},{"issue":"3","key":"3798_CR103","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1042\/BJ20041694","volume":"387","author":"B Karten","year":"2005","unstructured":"Karten B et al (2005) Generation and function of astroglial lipoproteins from Niemann-Pick type C1-deficient mice. Biochem J 387(3):779\u2013788","journal-title":"Biochem J"},{"issue":"2","key":"3798_CR104","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/ijms24021290","volume":"24","author":"N Zhan","year":"2023","unstructured":"Zhan N et al (2023) Identification of side chain oxidized sterols as novel liver X receptor agonists with therapeutic potential in the treatment of cardiovascular and neurodegenerative diseases. Int J Mol Sci 24(2):1290","journal-title":"Int J Mol Sci"},{"key":"3798_CR105","unstructured":"Wang S et al (2016) Is beta-amyloid accumulation a cause or consequence of Alzheimer's disease? J Alzheimers Parkinsonism Dement 1(2).\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5555607\/"},{"issue":"4","key":"3798_CR106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci 6(4):345\u2013351","journal-title":"Nat Neurosci"},{"issue":"4","key":"3798_CR107","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/jnc.12637","volume":"129","author":"WG Wood","year":"2014","unstructured":"Wood WG et al (2014) Cholesterol as a causative factor in Alzheimer\u2019s disease: a debatable hypothesis. J Neurochem 129(4):559\u2013572","journal-title":"J Neurochem"},{"issue":"5","key":"3798_CR108","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/138920310791330668","volume":"11","author":"G Eckert","year":"2010","unstructured":"Eckert G, Wood W, Muller W (2010) Lipid membranes and \u03b2-amyloid: a harmful connection. Curr Protein Pept Sci 11(5):319\u2013325","journal-title":"Curr Protein Pept Sci"},{"issue":"2","key":"3798_CR109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/156720511795256008","volume":"8","author":"R Williamson","year":"2011","unstructured":"Williamson R, Sutherland C (2011) Neuronal membranes are key to the pathogenesis of Alzheimer\u2019s disease: the role of both raft and non-raft membrane domains. Curr Alzheimer Res 8(2):213\u2013221","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"3798_CR110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","volume":"1259","author":"P Gamba","year":"2012","unstructured":"Gamba P et al (2012) The link between altered cholesterol metabolism and Alzheimer\u2019s disease. Ann N Y Acad Sci 1259(1):54\u201364","journal-title":"Ann N Y Acad Sci"},{"key":"3798_CR111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12035-012-8337-y","volume":"47","author":"M Maulik","year":"2013","unstructured":"Maulik M et al (2013) Role of cholesterol in APP metabolism and its significance in Alzheimer\u2019s disease pathogenesis. Mol Neurobiol 47:37\u201363","journal-title":"Mol Neurobiol"},{"issue":"9","key":"3798_CR112","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1073\/pnas.0813349106","volume":"106","author":"RW Halford","year":"2009","unstructured":"Halford RW, Russell DW (2009) Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer\u2019s disease, but does extend lifespan. Proc Natl Acad Sci 106(9):3502\u20133506","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"3798_CR113","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","volume":"111","author":"IJ Martins","year":"2009","unstructured":"Martins IJ et al (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease. J Neurochem 111(6):1275\u20131308","journal-title":"J Neurochem"},{"key":"3798_CR114","doi-asserted-by":"crossref","unstructured":"Koelsch G (2017) BACE1 function and inhibition: implications of intervention in the amyloid pathway of Alzheimer's disease pathology. Molecules 22(10).\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/29027981\/","DOI":"10.3390\/molecules22101723"},{"issue":"12","key":"3798_CR115","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","volume":"4","author":"LA Shobab","year":"2005","unstructured":"Shobab LA, Hsiung G-YR, Feldman HH (2005) Cholesterol in Alzheimer\u2019s disease. Lancet Neurol 4(12):841\u2013852","journal-title":"Lancet Neurol"},{"issue":"5","key":"3798_CR116","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","volume":"8","author":"LM Refolo","year":"2001","unstructured":"Refolo LM et al (2001) A cholesterol-lowering drug reduces \u03b2-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 8(5):890\u2013899","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3798_CR117","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1471-4159.2006.03925.x","volume":"98","author":"MP Burns","year":"2006","unstructured":"Burns MP et al (2006) The effects of ABCA1 on cholesterol efflux and A\u03b2 levels in vitro and in vivo. J Neurochem 98(3):792\u2013800","journal-title":"J Neurochem"},{"key":"3798_CR118","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.12659\/MSM.903636","volume":"23","author":"L Ya","year":"2017","unstructured":"Ya L, Lu Z (2017) Differences in ABCA1 R219K polymorphisms and serum indexes in Alzheimer and Parkinson Diseases in Northern China. Med Sci Monit: Int Med J Exp Clin Res 23:4591","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"issue":"4","key":"3798_CR119","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20268","volume":"56","author":"P Pals","year":"2004","unstructured":"Pals P et al (2004) \u03b1-Synuclein promoter confers susceptibility to Parkinson\u2019s disease. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 56(4):591\u2013595","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"15","key":"3798_CR120","doi-asserted-by":"publisher","first-page":"13244","DOI":"10.1074\/jbc.M300044200","volume":"278","author":"RP Koldamova","year":"2003","unstructured":"Koldamova RP et al (2003) 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid \u03b2 secretion. J Biol Chem 278(15):13244\u201313256","journal-title":"J Biol Chem"},{"issue":"3","key":"3798_CR121","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/STROKEAHA.114.007145","volume":"46","author":"X Cui","year":"2015","unstructured":"Cui X et al (2015) Deficiency of brain ATP-binding cassette transporter A-1 exacerbates blood\u2013brain barrier and white matter damage after stroke. Stroke 46(3):827\u2013834","journal-title":"Stroke"},{"issue":"1","key":"3798_CR122","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0896-6273(03)00840-7","volume":"41","author":"B Wolozin","year":"2004","unstructured":"Wolozin B (2004) Cholesterol and the biology of Alzheimer\u2019s disease. Neuron 41(1):7\u201310","journal-title":"Neuron"},{"key":"3798_CR123","doi-asserted-by":"publisher","first-page":"113698","DOI":"10.1016\/j.biopha.2022.113698","volume":"155","author":"Y Yamada","year":"2022","unstructured":"Yamada Y et al (2022) Fine-tuned cholesterol solubilizer, mono-6-O-\u03b1-D-maltosyl-\u03b3-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss. Biomed Pharmacother 155:113698","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3798_CR124","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/cells11030507","volume":"11","author":"M Liedtke","year":"2022","unstructured":"Liedtke M et al (2022) Impact of organelle transport deficits on mitophagy and autophagy in niemann-pick disease type c. Cells 11(3):507","journal-title":"Cells"},{"issue":"11","key":"3798_CR125","doi-asserted-by":"publisher","first-page":"e48143","DOI":"10.15252\/embr.201948143","volume":"20","author":"DN Mitroi","year":"2019","unstructured":"Mitroi DN et al (2019) NPC 1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP 46A1 activation. EMBO Rep 20(11):e48143","journal-title":"EMBO Rep"},{"issue":"10291","key":"3798_CR126","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. The Lancet 397(10291):2284\u20132303","journal-title":"The Lancet"},{"issue":"1","key":"3798_CR127","doi-asserted-by":"publisher","first-page":"e10367","DOI":"10.1002\/btm2.10367","volume":"8","author":"P Chopade","year":"2023","unstructured":"Chopade P et al (2023) Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng Transl Med 8(1):e10367","journal-title":"Bioeng Transl Med"},{"issue":"22","key":"3798_CR128","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.3390\/ijms222212198","volume":"22","author":"A Pierzchli\u0144ska","year":"2021","unstructured":"Pierzchli\u0144ska A, Dro\u017adzik M, Bia\u0142ecka M (2021) A possible role for HMG-CoA reductase inhibitors and its association with HMGCR genetic variation in Parkinson\u2019s disease. Int J Mol Sci 22(22):12198","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3798_CR129","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/aje\/kwj283","volume":"164","author":"LM De Lau","year":"2006","unstructured":"De Lau LM et al (2006) Serum cholesterol levels and the risk of Parkinson\u2019s disease. Am J Epidemiol 164(10):998\u20131002","journal-title":"Am J Epidemiol"},{"issue":"3","key":"3798_CR130","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mds.27609","volume":"34","author":"X Huang","year":"2019","unstructured":"Huang X et al (2019) Brain cholesterol metabolism and Parkinson\u2019s disease. Mov Disord 34(3):386\u2013395","journal-title":"Mov Disord"},{"issue":"1","key":"3798_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP et al (2015) Huntington disease. Nat Rev Dis Primers 1(1):1\u201321","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"3798_CR132","first-page":"1095","volume":"1851","author":"V Leoni","year":"2015","unstructured":"Leoni V, Caccia C (2015) The impairment of cholesterol metabolism in Huntington disease. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1851(8):1095\u20131105","journal-title":"Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids"},{"issue":"1","key":"3798_CR133","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1194\/jlr.P071639","volume":"58","author":"J Abdel-Khalik","year":"2017","unstructured":"Abdel-Khalik J et al (2017) Defective cholesterol metabolism in amyotrophic lateral sclerosis. J Lipid Res 58(1):267\u2013278","journal-title":"J Lipid Res"},{"key":"3798_CR134","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst J et al (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613\u2013617","journal-title":"J Neurol"},{"issue":"24","key":"3798_CR135","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1111\/febs.16175","volume":"289","author":"H Hartmann","year":"2022","unstructured":"Hartmann H et al (2022) Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon? FEBS J 289(24):7688\u20137709","journal-title":"FEBS J"},{"issue":"4","key":"3798_CR136","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler RG et al (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress\u2013induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 52(4):448\u2013457","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"12","key":"3798_CR137","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1089\/ars.2018.7506","volume":"29","author":"E Popugaeva","year":"2018","unstructured":"Popugaeva E, Pchitskaya E, Bezprozvanny I (2018) Dysregulation of intracellular calcium signaling in Alzheimer\u2019s disease. Antioxid Redox Signal 29(12):1176\u20131188","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"3798_CR138","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jalz.2018.05.017","volume":"14","author":"EJ Kodis","year":"2018","unstructured":"Kodis EJ et al (2018) N-methyl-D-aspartate receptor\u2013mediated calcium influx connects amyloid-\u03b2 oligomers to ectopic neuronal cell cycle reentry in Alzheimer\u2019s disease. Alzheimers Dement 14(10):1302\u20131312","journal-title":"Alzheimers Dement"},{"issue":"24","key":"3798_CR139","doi-asserted-by":"publisher","first-page":"e2127","DOI":"10.1212\/WNL.0000000000005677","volume":"90","author":"S Oveisgharan","year":"2018","unstructured":"Oveisgharan S et al (2018) APOE \u03b52\u03b54 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology 90(24):e2127\u2013e2134","journal-title":"Neurology"},{"issue":"20","key":"3798_CR140","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/0006-2952(80)90006-4","volume":"29","author":"RJ Cenedella","year":"1980","unstructured":"Cenedella RJ (1980) Concentration-dependent effects of AY-9944 and U18666A on sterol synthesis in brain: Variable sensitivities of metabolic steps. Biochem Pharmacol 29(20):2751\u20132754","journal-title":"Biochem Pharmacol"},{"key":"3798_CR141","doi-asserted-by":"crossref","unstructured":"Das S et al (2023) Distinct transcriptomic responses to A beta plaques, neurofibrillary tangles, and APOE in Alzheimer's disease. bioRxiv p. 2023.03. 20.533303.\u00a0https:\/\/www.biorxiv.org\/content\/10.1101\/2023.03.20.533303v1","DOI":"10.1101\/2023.03.20.533303"},{"issue":"18","key":"3798_CR142","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.neuron.2022.06.021","volume":"110","author":"M Otero-Garcia","year":"2022","unstructured":"Otero-Garcia M et al (2022) Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer\u2019s disease. Neuron 110(18):2929-2948. e8","journal-title":"Neuron"},{"key":"3798_CR143","doi-asserted-by":"crossref","unstructured":"Batra S et al (2023) A review on cyclin-dependent kinase 5: an emerging drug target for neurodegenerative diseases. Int J Biol Macromol 123259.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/36641018\/","DOI":"10.1016\/j.ijbiomac.2023.123259"},{"issue":"15","key":"3798_CR144","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.3390\/ijms22158096","volume":"22","author":"T Hirokawa","year":"2021","unstructured":"Hirokawa T et al (2021) Roscovitine, a cyclin-dependent kinase-5 inhibitor, decreases phosphorylated Tau formation and death of retinal ganglion cells of rats after optic nerve crush. Int J Mol Sci 22(15):8096","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3798_CR145","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.cellsig.2005.12.006","volume":"18","author":"CHV Koh","year":"2006","unstructured":"Koh CHV et al (2006) U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Signal 18(10):1572\u20131583","journal-title":"Cell Signal"},{"issue":"4","key":"3798_CR146","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1523\/JNEUROSCI.23-04-01189.2003","volume":"23","author":"T Saito","year":"2003","unstructured":"Saito T et al (2003) Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J Neurosci 23(4):1189\u20131197","journal-title":"J Neurosci"},{"key":"3798_CR147","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-002-0587-8","volume":"104","author":"I Ferrer","year":"2002","unstructured":"Ferrer I, Barrachina M, Puig B (2002) Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 104:583\u2013591","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3798_CR148","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","volume":"71","author":"DP Hanger","year":"1998","unstructured":"Hanger DP et al (1998) New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer\u2019s disease brain using nanoelectrospray mass spectrometry. J Neurochem 71(6):2465\u20132476","journal-title":"J Neurochem"},{"issue":"6938","key":"3798_CR149","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ et al (2003) GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides. Nature 423(6938):435\u2013439","journal-title":"Nature"},{"issue":"4","key":"3798_CR150","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.0022-3042.2001.00728.x","volume":"80","author":"R Hashimoto","year":"2002","unstructured":"Hashimoto R et al (2002) Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 80(4):589\u2013597","journal-title":"J Neurochem"},{"issue":"1","key":"3798_CR151","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1020932130753","volume":"24","author":"SM Sparrow","year":"1999","unstructured":"Sparrow SM et al (1999) U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells. Neurochem Res 24(1):69\u201378","journal-title":"Neurochem Res"},{"issue":"14","key":"3798_CR152","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.7150\/ijbs.63512","volume":"17","author":"T Liu","year":"2021","unstructured":"Liu T et al (2021) Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling. Int J Biol Sci 17(14):3702","journal-title":"Int J Biol Sci"},{"issue":"10","key":"3798_CR153","doi-asserted-by":"publisher","first-page":"dmm048929","DOI":"10.1242\/dmm.048929","volume":"14","author":"Q Wu","year":"2021","unstructured":"Wu Q et al (2021) Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer\u2019s disease pathology. Dis Models Mech 14(10):dmm048929","journal-title":"Dis Models Mech"},{"issue":"16","key":"3798_CR154","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.3390\/ijms22168858","volume":"22","author":"A Bernardo","year":"2021","unstructured":"Bernardo A et al (2021) Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives. Int J Mol Sci 22(16):8858","journal-title":"Int J Mol Sci"},{"key":"3798_CR155","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuropharm.2013.05.035","volume":"73","author":"E Coppi","year":"2013","unstructured":"Coppi E et al (2013) Adenosine A2A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures. Neuropharmacology 73:301\u2013310","journal-title":"Neuropharmacology"},{"issue":"1","key":"3798_CR156","doi-asserted-by":"publisher","first-page":"9782","DOI":"10.1038\/s41598-019-46268-8","volume":"9","author":"C De Nuccio","year":"2019","unstructured":"De Nuccio C et al (2019) Adenosine A2A receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes. Sci Rep 9(1):9782","journal-title":"Sci Rep"},{"issue":"5","key":"3798_CR157","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/mds.28396","volume":"36","author":"P Garc\u00eda-Sanz","year":"2021","unstructured":"Garc\u00eda-Sanz P, Aerts JMFG, Moratalla R (2021) The role of cholesterol in \u03b1-synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease. Mov Disord 36(5):1070\u20131085","journal-title":"Mov Disord"},{"issue":"6","key":"3798_CR158","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/brain\/awx094","volume":"140","author":"R Desai","year":"2017","unstructured":"Desai R et al (2017) ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism. Brain 140(6):1595\u20131610","journal-title":"Brain"},{"issue":"3","key":"3798_CR159","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0002-9440(10)63185-9","volume":"164","author":"L-W Jin","year":"2004","unstructured":"Jin L-W et al (2004) Intracellular accumulation of amyloidogenic fragments of amyloid-\u03b2 precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol 164(3):975\u2013985","journal-title":"Am J Pathol"},{"issue":"3","key":"3798_CR160","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","volume":"287","author":"CD Lee","year":"2012","unstructured":"Lee CD et al (2012) Apolipoprotein E promotes \u03b2-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem 287(3):2032\u20132044","journal-title":"J Biol Chem"},{"issue":"12","key":"3798_CR161","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.chembiol.2016.10.015","volume":"23","author":"GM Finan","year":"2016","unstructured":"Finan GM et al (2016) Bioactive compound screen for pharmacological enhancers of apolipoprotein E in primary human astrocytes. Cell Chem Biol 23(12):1526\u20131538","journal-title":"Cell Chem Biol"},{"issue":"11","key":"3798_CR162","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/glia.23191","volume":"65","author":"H Yang","year":"2017","unstructured":"Yang H, Wang Y, Kar S (2017) Effects of cholesterol transport inhibitor U18666A on APP metabolism in rat primary astrocytes. Glia 65(11):1728\u20131743","journal-title":"Glia"},{"issue":"1","key":"3798_CR163","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12031-013-0209-z","volume":"53","author":"G Muirhead","year":"2014","unstructured":"Muirhead G, Dev KK (2014) The expression of neuronal sorting nexin 8 (SNX8) exacerbates abnormal cholesterol levels. J Mol Neurosci 53(1):125\u2013134","journal-title":"J Mol Neurosci"},{"key":"3798_CR164","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/B978-0-323-85857-1.00038-9","volume-title":"Cholesterol","author":"A \u0141ugowska","year":"2022","unstructured":"\u0141ugowska A (2022) Niemann-Pick type C disease (NPC). Cholesterol. Elsevier, pp 525\u2013551"},{"issue":"12","key":"3798_CR165","doi-asserted-by":"publisher","first-page":"e82685","DOI":"10.1371\/journal.pone.0082685","volume":"8","author":"BE Kennedy","year":"2013","unstructured":"Kennedy BE et al (2013) Pre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick Type C1-deficient murine brain. PLoS one 8(12):e82685","journal-title":"PLoS one"},{"issue":"4","key":"3798_CR166","doi-asserted-by":"publisher","first-page":"e1003462","DOI":"10.1371\/journal.pgen.1003462","volume":"9","author":"T Yu","year":"2013","unstructured":"Yu T, Lieberman AP (2013) Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin. PLoS Genet 9(4):e1003462","journal-title":"PLoS Genet"},{"issue":"7","key":"3798_CR167","first-page":"659","volume":"1791","author":"B Karten","year":"2009","unstructured":"Karten B, Peake KB, Vance JE (2009) Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1791(7):659\u2013670","journal-title":"Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids"},{"issue":"10","key":"3798_CR168","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11745-015-4062-4","volume":"50","author":"D Copetti-Santos","year":"2015","unstructured":"Copetti-Santos D et al (2015) U18666a treatment results in cholesterol accumulation, reduced Na+, K+-ATPase activity, and increased oxidative stress in rat cortical astrocytes. Lipids 50(10):937\u2013944","journal-title":"Lipids"},{"issue":"7","key":"3798_CR169","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jocn.2008.09.020","volume":"16","author":"S Ishibashi","year":"2009","unstructured":"Ishibashi S, Yamazaki T, Okamoto K (2009) Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells. J Clin Neurosci 16(7):954\u2013959","journal-title":"J Clin Neurosci"},{"issue":"1","key":"3798_CR170","doi-asserted-by":"publisher","first-page":"e0147208","DOI":"10.1371\/journal.pone.0147208","volume":"11","author":"AR Marques","year":"2016","unstructured":"Marques AR et al (2016) Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease. PLoS One 11(1):e0147208","journal-title":"PLoS One"},{"issue":"1","key":"3798_CR171","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/ijms22010452","volume":"22","author":"M Fukaura","year":"2021","unstructured":"Fukaura M et al (2021) Intracerebroventricular treatment with 2-hydroxypropyl-\u03b2-cyclodextrin decreased cerebellar and hepatic glycoprotein nonmetastatic melanoma protein B (GPNMB) expression in Niemann-Pick disease type C model mice. Int J Mol Sci 22(1):452","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3798_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-46268-8","volume":"9","author":"C De Nuccio","year":"2019","unstructured":"De Nuccio C et al (2019) Adenosine A2A receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes. Sci Rep 9(1):1\u201310","journal-title":"Sci Rep"},{"key":"3798_CR173","unstructured":"Shin Y (2013) Donepezil enhances Purkinje cell survival and improves motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann Pick type C disease.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/24487798\/"},{"issue":"9","key":"3798_CR174","doi-asserted-by":"publisher","first-page":"e21980","DOI":"10.1002\/syn.21980","volume":"71","author":"M Schmitt","year":"2017","unstructured":"Schmitt M et al (2017) U18666A, an activator of sterol regulatory element binding protein pathway, modulates presynaptic dopaminergic phenotype of SH-SY5Y neuroblastoma cells. Synapse 71(9):e21980","journal-title":"Synapse"},{"issue":"5","key":"3798_CR175","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/neup.12380","volume":"37","author":"T Kodachi","year":"2017","unstructured":"Kodachi T et al (2017) Severe demyelination in a patient with a late infantile form of Niemann-Pick disease type C. Neuropathology 37(5):426\u2013430","journal-title":"Neuropathology"},{"key":"3798_CR176","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.redox.2016.11.010","volume":"11","author":"S Torres","year":"2017","unstructured":"Torres S et al (2017) Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease. Redox Biol 11:60\u201372","journal-title":"Redox Biol"},{"issue":"6","key":"3798_CR177","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/jnen\/63.6.660","volume":"63","author":"S Takikita","year":"2004","unstructured":"Takikita S et al (2004) Perturbed myelination process of premyelinating oligodendrocyte in niemann-picktype C mouse. J Neuropathol Exp Neurol 63(6):660\u2013673","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"3798_CR178","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","volume":"417","author":"A Martire","year":"2007","unstructured":"Martire A et al (2007) Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington\u2019s disease versus wild-type mice. Neurosci Lett 417(1):78\u201383","journal-title":"Neurosci Lett"},{"issue":"1","key":"3798_CR179","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00284-022-03112-z","volume":"80","author":"S Sedighi","year":"2023","unstructured":"Sedighi S et al (2023) Comprehensive Investigations relationship between viral infections and multiple sclerosis pathogenesis. Curr Microbiol 80(1):15","journal-title":"Curr Microbiol"},{"issue":"1","key":"3798_CR180","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3181\/00379727-112-28003","volume":"112","author":"WA Phillips","year":"1963","unstructured":"Phillips WA, Avigan J (1963) Inhibition of cholesterol biosynthesis in the rat by 3 \u03b2-(2-diethylaminoethoxy) androst-5-en-17-one, hydrochloride. Proc Soc Exp Biol Med 112(1):233\u2013236","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"3798_CR181","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0006-8993(78)90285-8","volume":"150","author":"GG Bierkamper","year":"1978","unstructured":"Bierkamper GG, Cenedella RJ (1978) Induction of chronic epileptiform activity in the rat by an inhibitor of cholesterol synthesis, U18666A. Brain Res 150(2):343\u2013351","journal-title":"Brain Res"},{"issue":"3","key":"3798_CR182","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1528-1157.1982.tb06190.x","volume":"23","author":"RJ Cenedella","year":"1982","unstructured":"Cenedella RJ, Sarkar CP, Towns L (1982) Studies on the mechanism of the epileptiform activity induced by U18666A. II. Concentration, half-life and distribution of radiolabeled U18666A in the brain. Epilepsia 23(3):257\u201368","journal-title":"Epilepsia"},{"issue":"11","key":"3798_CR183","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.3390\/ijms22115698","volume":"22","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ma X, Hu H (2021) Application of nano-drug delivery system based on cascade technology in cancer treatment. Int J Mol Sci 22(11):5698","journal-title":"Int J Mol Sci"},{"key":"3798_CR184","doi-asserted-by":"crossref","unstructured":"Amaral M, Pereiro AB (2021) Recent advances in ionic liquids and nanotechnology for drug delivery. 16(1):63-80.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33356551\/","DOI":"10.2217\/nnm-2020-0340"},{"key":"3798_CR185","doi-asserted-by":"crossref","unstructured":"Jhaveri J, Raichura Z, Khan T (2021) Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics. 26(2).\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33430478\/","DOI":"10.3390\/molecules26020272"},{"issue":"1","key":"3798_CR186","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12951-022-01625-0","volume":"20","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S et al (2022) An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnology 20(1):440","journal-title":"J Nanobiotechnology"},{"key":"3798_CR187","doi-asserted-by":"crossref","unstructured":"Yasamineh S et al (2022) A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm p. 121878.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/35636629\/","DOI":"10.1016\/j.ijpharm.2022.121878"},{"issue":"1","key":"3798_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-022-01935-7","volume":"19","author":"O Gholizadeh","year":"2022","unstructured":"Gholizadeh O et al (2022) Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virol J 19(1):1\u201322","journal-title":"Virol J"},{"issue":"12","key":"3798_CR189","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/j.bbamem.2016.09.013","volume":"1858","author":"Y-U Bae","year":"2016","unstructured":"Bae Y-U et al (2016) Enhancement of liposome mediated gene transfer by adding cholesterol and cholesterol modulating drugs. Biochim Biophys Acta (BBA)-Biomembr 1858(12):3017\u20133023","journal-title":"Biochim Biophys Acta (BBA)-Biomembr"},{"key":"3798_CR190","doi-asserted-by":"publisher","first-page":"705886","DOI":"10.3389\/fbioe.2021.705886","volume":"9","author":"P Nakhaei","year":"2021","unstructured":"Nakhaei P et al (2021) Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol. Front Bioeng Biotechnol 9:705886","journal-title":"Front Bioeng Biotechnol"},{"issue":"10","key":"3798_CR191","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.bbamem.2015.06.020","volume":"1848","author":"B-K Kim","year":"2015","unstructured":"Kim B-K et al (2015) DOTAP\/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes. Biochim Biophys Acta (BBA)-Biomembr 1848(10):1996\u20132001","journal-title":"Biochim Biophys Acta (BBA)-Biomembr"},{"issue":"5","key":"3798_CR192","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/smll.201201811","volume":"9","author":"RE Yanes","year":"2013","unstructured":"Yanes RE et al (2013) Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of drug delivery effect by exocytosis inhibition. Small 9(5):697","journal-title":"Small"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03798-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03798-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03798-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T09:28:57Z","timestamp":1715333337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03798-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":192,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["3798"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03798-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors guarantee that, once their material has been accepted for publication by the journal, they will not submit the same material or portions thereof to another journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}